ALFUZOSIN HYDROCHLORIDE
Substance profile for UNII 75046A1XTN, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.
Structure render from NCI/CADD chemical resolverSubstance Identity#
- UNII
- 75046A1XTN
- Preferred term
- ALFUZOSIN HYDROCHLORIDE
- Registry number
- 81403-68-1
- Ingredient type
- INGREDIENT SUBSTANCE
- Molecular formula
- C19H27N5O4.ClH
Chemical And Database Identifiers#
- SMILES
- Cl.COC1=CC2=C(C=C1OC)C(N)=NC(=N2)N(C)CCCNC(=O)C3CCCO3
- RxCUI
- 46043
- PubChem
- 0
- NCIt
- C53408
- INN ID
- 0
DailyMed Socrata Ingredients#
DailyMed label, SPL version table| DailyMed label | SPL version |
|---|
| These highlights do not include all the information needed to use alfuzosin hydrochloride safely and effectively. See full prescribing information for alfuzosin hydrochloride extended-release tablets. Alfuzosin Hydrochloride Extended-Release Tablets Initial U.S. Approval: 2003 | 2 |
| These highlights do not include all the information needed to use UROXATRAL safely and effectively. See full prescribing information for UROXATRAL. UROXATRAL ® (alfuzosin HCl) extended-release tablets Initial U.S. Approval: 2003 | 1 |
| These highlights do not include all the information needed to use alfuzosin HCl extended-release tablets safely and effectively. See full prescribing information for alfuzosin HCl extended-release tablets. Alfuzosin Hydrochloride Extended-Release Tablets Initial U.S. Approval: 2003 | 1 |
| These highlights do not include all the information needed to use alfuzosin hydrochloride extended-release tablets safely and effectively. See full prescribing information for alfuzosin hydrochloride extended-release tablets. Alfuzosin Hydrochloride Extended-Release Tablets Initial U.S. Approval: 2003 | 3 |
| These highlights do not include all the information needed to use Alfuzosin Hydrochloride safely and effectively. See full prescribing information for Alfuzosin Hydrochloride. Alfuzosin Hydrochloride (Alfuzosin Hydrochloride) TABLET for ORAL use. Initial U.S. Approval: 2003 | 1 |
| UROXATRAL (alfuzosin hydrochloride) tablet, extended release | 2 |
| UROXATRAL (ALFUZOSIN HYDROCHLORIDE) TABLET, EXTENDED RELEASE [SANOFI-AVENTIS U.S. LLC] | 15 |
| ALFUZOSIN HYDROCHLORIDE TABLET, EXTENDED RELEASE [APOTEX CORP.] | 9 |
| ALFUZOSIN HYDROCHLORIDE TABLET, EXTENDED RELEASE [SUN PHARMA GLOBAL FZE] | 8 |
| ALFUZOSIN HYDROCHLORIDE (ALFUZOSIN) TABLET, EXTENDED RELEASE [MYLAN PHARMACEUTICALS INC.] | 7 |
| ALFUZOSIN HYDROCHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [AUROBINDO PHARMA LIMITED] | 7 |
| ALFUZOSIN HYDROCHLORIDE ER (ALFUZOSIN HYDROCHLORIDE) TABLET, EXTENDED RELEASE [AVKARE, INC.] | 6 |
| ALFUZOSIN HYDROCHLORIDE TABLET, EXTENDED RELEASE [TORRENT PHARMACEUTICALS LIMITED] | 6 |
| ALFUZOSIN HYDROCHLORIDE (ALFUZOSIN HYDROCHLORIDE ) TABLET, EXTENDED RELEASE [EXELAN PHARMACEUTICALS INC.] | 2 |
| ALFUZOSIN HYDROCHLORIDE TABLET [WOCKHARDT USA LLC.] | 2 |
| ALFUZOSIN HYDROCHLORIDE TABLET, EXTENDED RELEASE [GOLDEN STATE MEDICAL SUPPLY, INC.] | 2 |
| UROXATRAL (ALFUZOSIN HCL) TABLET, EXTENDED RELEASE [COVIS PHARMACEUTICALS INC.] | 2 |
| ALFUZOSIN HYDROCHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [CITRON PHARMA LLC] | 1 |
| UROXATRAL (ALFUZOSIN HCL) TABLET, EXTENDED RELEASE [CONCORDIA PHARMACEUTICALS INC.] | 1 |
mor.nlm.nih.gov/RxNav/search?searchBy=RXCUI&searchTerm=46043
ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C53408
precision.fda.gov/uniisearch/srs/unii/75046A1XTN